Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

2.

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ; M2-124 and M2-125 study groups.

Lancet. 2009 Aug 29;374(9691):685-94. doi: 10.1016/S0140-6736(09)61255-1. Erratum in: Lancet. 2010 Oct 2;376(9747):1146.

PMID:
19716960
3.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
4.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

5.

Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia.

San Pedro GS, Cammarata SK, Oliphant TH, Todisco T; Linezolid Community-Acquired Pneumonia Study Group.

Scand J Infect Dis. 2002;34(10):720-8.

PMID:
12477321
6.

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr.

Eur Respir J. 2002 Feb;19(2):217-24.

7.

Are quantitative cultures useful in the diagnosis of hospital-acquired pneumonia?

San Pedro G.

Chest. 2001 Feb;119(2 Suppl):385S-390S.

PMID:
11171774
8.

Treating acute exacerbations of chronic bronchitis.

San Pedro G, George R.

Hosp Pract (1995). 2000 Nov 15;35(11):43-50. Review.

PMID:
11108005
9.

Empiric therapy of community-acquired pneumonia.

Green DS, San Pedro GS.

Semin Respir Infect. 2000 Sep;15(3):227-33. Review.

PMID:
11052423
10.

Pulmonary rehabilitation for the patient with severe chronic obstructive pulmonary disease.

San Pedro GS.

Am J Med Sci. 1999 Aug;318(2):99-102. Review.

PMID:
10452568
11.

Introduction to symposium on chronic obstructive pulmonary disease.

George RB, San Pedro GS.

Am J Med Sci. 1999 Aug;318(2):73. No abstract available.

PMID:
10452562
12.

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S.

Lancet. 1998 Mar 28;351(9107):929-33.

PMID:
9734938
13.

Limitations of diagnostic testing in the initial management of patients with community-acquired pneumonia.

San Pedro GS, Campbell GD Jr.

Semin Respir Infect. 1997 Dec;12(4):300-7. Review.

PMID:
9436957
14.

Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses.

Olsen KM, San Pedro G, Gann LP, Gubbins PO, Halinski DM, Campbell GD Jr.

Antimicrob Agents Chemother. 1996 Nov;40(11):2582-5.

15.

Using standardized patients to teach breast evaluation to sophomore medical students.

Heard JK, Cantrell M, Presher L, Klimberg VS, San Pedro GS, Erwin DO.

J Cancer Educ. 1995 Winter;10(4):191-4.

PMID:
8924392

Supplemental Content

Loading ...
Support Center